Pharmaceutical Outsourcing And Supply Chain Resilience Will Drive Future Expansion

Shared on23 Apr 25
Fair value Increased 14%

Shared on17 Apr 25
Fair value Decreased 0.17%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25
Fair value Increased 0.17%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Decreased 0.43%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on12 Mar 25
Fair value Decreased 14%

AnalystConsensusTarget has decreased future PE multiple from 27.5x to 24.3x.